Alexion, AstraZeneca Rare Disease, Boston, MA, USABoston, Massachusetts, United States
Disclosure information not submitted.
MON-765 - Chronic Hypoparathyroidism in the US: Prevalence and Incidence from 2018 to 2024, with Baseline Clinical Characteristics
Monday, June 15, 20269:00 AM - 2:00 PM CT